The Valley Desk

ArticleEClinicalMedicinePublished

Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Article
Venue
EClinicalMedicine
Published
Subject terms
Metastatic Colorectal Cancer; Regorafenib; Nivolumab; Microsatellite Stable; Mismatch Repair-proficient
PubMed ID
37090438
PubMed Central ID
PMC10119887
Added to directory
Source checked

Report a correction or request removal